欧洲青光眼学会青光眼诊疗研究优先事项
本研究采用三轮方法(两轮电子德尔菲调查和一天研讨会),纳入27个欧洲国家的308例患者和150名临床医生,确定青光眼研究优先事项。患者和临床医生共同最高优先事项为「恢复视力的治疗」,前三项优先事项为「阻止视力丧失的治疗」「恢复视力的治疗」和「改进青光眼恶化检测」。
要点
- 患者和临床医生共同最高优先事项为「恢复视力的治疗」。
- 前三项优先事项为「阻止视力丧失的治疗」「恢复视力的治疗」「改进青光眼恶化检测」。
- 第一阶段纳入308例患者和150名临床医生,第三阶段8例患者和4名临床医生参与。
核心结论
- 研究制定了涉及欧洲不同国家临床医生和患者的青光眼研究优先事项清单,将有助于指导研究工作和投资。
研究设计与样本
- 采用三阶段方法,包括两轮电子德尔菲调查和一天研讨会;临床医生与患者电子调查平行独立进行。
- 第一阶段调查以6种语言分发给27个欧洲国家的患者和欧洲青光眼学会成员(青光眼诊疗专长眼科医生),要求列出最多五项研究优先事项。
- 第二阶段要求参与者用Likert量表对第一阶段确定的问题进行排序;第三阶段为一天研讨会,患者和临床医生基于前20项优先事项决定最重要的10项研究优先事项。
- 第一阶段纳入308例患者和150名临床医生;第三阶段纳入8例患者和4名临床医生。
主要发现
- 第二阶段患者和临床医生最高排名优先事项均为「恢复视力的治疗」。
- 第三阶段前三项优先事项为「阻止视力丧失的治疗」「恢复视力的治疗」和「改进青光眼恶化检测」。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: The goal of health research is to improve patients care and outcomes. Thus, it is essential that research addresses questions that are important to patients and clinicians. The aim of this study was to develop a list of priorities for glaucoma research involving stakeholders from different countries in Europe. METHODS: We used a three-phase method, including a two-round electronic Delphi survey and a workshop. The clinician and patient electronic surveys were conducted in parallel and independently. For phase I, the survey was distributed to patients from 27 European countries in 6 different languages, and to European Glaucoma Society members, ophthalmologists with expertise in glaucoma care, asking to name up to five research priorities. During phase II, participants were asked to rank the questions identified in phase I using a Likert scale. Phase III was a 1 day workshop with patients and clinicians. The purpose was to make decisions about the 10 most important research priorities using the top 20 priorities identified by patients and clinicians. RESULTS: In phase I, 308 patients and 150 clinicians were involved. In phase II, the highest-ranking priority for both patients and clinicians was 'treatments to restore vision'. In phase III, eight patients and four clinicians were involved. The top three priorities were 'treatments to stop sight loss', 'treatments to restore vision' and 'improved detection of worsening glaucoma'. CONCLUSION: We have developed a list of priorities for glaucoma research involving clinicians and patients from different European countries that will help guide research efforts and investment.
引用
- Azuara-Blanco A, McCorry N, Tatham AJ, et al. European Glaucoma Society research priorities for glaucoma care. Br J Ophthalmol. 2024. PMID: 37923373. doi:10.1136/bjo-2023-323648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。